Besides exploring the company profiles of prominent market leaders, the research gather and analyses raw data on the regulatory framework, cost structure, import and export status, supply chain management and supply chain management expected to shape the trajectory of the business landscape. The researchers behind the study have further leveraged the industry-leading assessment tools to gauge the growing level of competition, recent acquisition and mergers, product launches and new entrants. The global spinal implants and surgery devices market is projected to be worth USD 14.70 Billion by 2027, according to a current analysis by Emergen Research.
Key Highlights From The Report
In March 2019, RTI Surgical Holdings, Inc., a firm involved in surgical implant, made an announcement about the completion of the acquisition of Paradigm Spine, LLC, involved in non-fusion and motion preservation spinal implant technology.
Spine biologics are likely to grow at a significant rate in the forecast period, owing to the increasing demand for spine implants. These are deployed to accomplish arthrodesis during the treatment of symptomatic deformity/instability treatment.
Spine fusion finds widespread usage in the treatment of spine tumors, trauma, and degenerative disorders.
The key advantage of motion preservation spine surgery is in offering patients with major structural spinal issues a better substitute to spinal fusion that is a time-consuming procedure.
North America, led by the US, dominated the market in 2019. The spinal implants and surgery devices market dominance of North America is due to the rapid technological advancement and adoption in healthcare, growing geriatric population, and improved reimbursement policies to incentivize intricate fusion surgery in spinal implants.
Key participants include Stryker Corporation, RTI Surgical Inc., Nuvasive Inc., Zimmer Biomet Holdings Inc., Boston Scientific, Depuy Synthes, B. Braun Melsungen, Abbott Laboratories, Orthofix International NV, and Medtronic PLC, among others.
Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA
Product Type Outlook (Revenue, USD Billion; 2017-2027)
Thoracic Fusion & Lumbar Fusion Devices
Posterior
Interbody
Cervical Fusion Devices
Anterior
Posterior
Spine Biologics
Vertebral Compression Fracture Treatment Devices
Spinal Decompression Devices
Spine Bone Stimulators
Invasive
Non-Invasive
Non-Fusion Devices
Dynamic Stabilization Devices
Artificial Discs
Annulus Repair Devices
Nuclear Disc Prostheses
Technology Outlook (Revenue, USD Billion; 2017-2027)
Spinal Fusion & Fixation
Vertebral Compression Fracture Treatment
Spinal Decompression
Motion Preservation
Surgery Type Outlook (Revenue, USD Billion; 2017-2027)
Open Surgery
Minimally Invasive Surgery
End-User Outlook (Revenue, USD Billion; 2017-2027)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
